Baraitser–Winter syndrome (BWS) is rare, and no previous reports have described the visual course of patients with this condition. Herein, we report the long-term visual outcomes and ocular features of a 6-yea... … [Read more...] about Ocular findings in Baraitser–Winter syndrome with a de novo mutation in the ACTG1 gene: a case report
News
Standard surgical approaches have better outcomes in trachomatous trichiasis
December 04, 2024 1 min read Key takeaways: A study explored bilamellar tarsal rotation with 3 mm or 5 mm incision height and posterior lamellar tarsal rotation. Postoperative trichiasis was more likely with the 5 mm approach. Two standard surgical procedures helped treat patients with trachomatous trichiasis, according to a study … [Read more...] about Standard surgical approaches have better outcomes in trachomatous trichiasis
Regener-Eyes launches backflow prevention bottles, recalls products with previous design
December 04, 2024 1 min read Regener-Eyes has launched a new preservative-free, multidose bottle with an improved design to prevent backflow and avoid bacterial contamination, according to a company press release. “Following last week’s discussion with the FDA, we are confident that our new preservative-free bottles meet the standards for backflow prevention for … [Read more...] about Regener-Eyes launches backflow prevention bottles, recalls products with previous design
Part 4: Advice from the experts: Helpful information for current residents
In this series, experts in the field advise current residents and offer insight into how they can make the most of their time and experience moving forward with their careers.Video Transcript:Editor's note: The below transcript has been lightly edited for clarity.Constance Okeke, MD:The advice that I would give a resident is to take some time and find out what really gets you … [Read more...] about Part 4: Advice from the experts: Helpful information for current residents
Over 300 patients randomized in Ocular Therapeutix’s SOL-1 phase 3 trial for OTX-TKI
More than 300 patients have been randomized in the SOL-1 Phase 3 trial for OTX-TKI (AXPAXLI, axitinib intravitreal implant). The trial is expected to close randomization in early December 2024. This is the first registrational clinical trial of OTX-TKI in wet age-related macular degeneration (wet AMD) and is on track to report topline data in the fourth quarter of 2025.1Pravin … [Read more...] about Over 300 patients randomized in Ocular Therapeutix’s SOL-1 phase 3 trial for OTX-TKI
VIDEO: Results of real-world suprachoroidal triamcinolone acetonide positive
December 04, 2024 3 min watch CHICAGO — In this Healio Video Perspective from the AAO meeting, Dilraj Grewal, MD, FASRS, of Duke Eye Center shares real-world data on suprachoroidal triamcinolone acetonide for noninfectious uveitis with macular edema. In a retrospective analysis, 27 eyes were treated with a suprachoroidal injection of triamcinolone acetonide 40 mg and … [Read more...] about VIDEO: Results of real-world suprachoroidal triamcinolone acetonide positive
EyePoint doses first patient in second global Phase 3 LUCIA clinical trial of Duravyu for the treatment of wet AMD
EyePoint Pharmaceuticals Inc. has announced the successful dosing of the first patient in the LUCIA trial, marking the initiation of the company’s second global Phase 3 clinical study of Duravyu (formerly EYP-1901) for the treatment of wet age-related macular degeneration (wet AMD).Duravyu is an investigational sustained-release therapy that delivers patent-protected vorolanib, … [Read more...] about EyePoint doses first patient in second global Phase 3 LUCIA clinical trial of Duravyu for the treatment of wet AMD
Foundation Fighting Blindness joins University of Colorado Anschutz Medical Campus and leading institutions receive funding to fast track whole eye transplantation program
The Foundation Fighting Blindness this week announced that the Advanced Research Projects Agency for Health (ARPA-H), a division of the US Department of Health and Human Services, has awarded up to $46 million to the University of Colorado Anschutz Medical Campus, the Foundation, and 6 other research groups. This funding will support research and innovation in vision-restoring … [Read more...] about Foundation Fighting Blindness joins University of Colorado Anschutz Medical Campus and leading institutions receive funding to fast track whole eye transplantation program
SMILE and ICL implantation on the ocular surface and meibomian glands in patients with postoperative myopia
Objectively compare the changes in ocular surface parameters in myopic patients who have undergone either SMILE or Implantable Collamer Lens (ICL V4c) surgery. … [Read more...] about SMILE and ICL implantation on the ocular surface and meibomian glands in patients with postoperative myopia
Four teams receive funding for eye transplantation research
December 03, 2024 2 min read The Advanced Research Projects Agency for Health announced funding worth up to $125 million to help four teams research eye transplantation, according to a press release. The funding is from the agency’s Transplantation of Human Eye Allografts (THEA) program and aims to help the research teams develop the first complete transplant of human … [Read more...] about Four teams receive funding for eye transplantation research